Overview IPOs often deliver strong short-term gains, but many underperform in the long run compared to secondary market ...

This week, the secondary copper rod market exhibited a complex situation under the dual influence of macro policies and price fluctuations. After the US Fed announced a 25bp interest rate cut in ...

A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the ...

Panelists discuss how the BE OPTIMAL study enrolled biologic-naive patients, whereas BE COMPLETE enrolled TNF inhibitor-inadequate responders. Both populations showed similar response rates despite ...

The development of artificial intelligence in medicine and pharmacy has been discussed for years, but there is still no ...

Background The ‘right to request’ flexible working policy has been gradually extended and, by 2014, extended to cover all ...

Experts explore the potential of invasive disease-free survival as a key metric in breast cancer trials, aiming to accelerate ...

When the JWST finally began its long-awaited science operations in July 2022, there was a long list of targets awaiting its ...

After an acute MI in patients with only a mild reduction in left ventricular ejection fraction, new data show that beta-blockers have a relatively modest benefit.

Bullish and Bearish Factors Intertwined in the Market, Lead Prices Maintain Narrow Fluctuations] The State Council: Launch comprehensive reform pilots for market-based allocation of factors in 10 ...

The report highlighted the successes in access, improving gender equality, the growing attention to issues of quality ...

This month’s savage reaction to Argenica Therapeutics' (ASX:AGN) stroke drug trial results shows that investors didn’t buy ...